Ep. 245 - Biotech-Academia Deals, Leqembi's Latest, Wilson Moves On

Aug 6, 2024

Delve into the evolving partnerships between biotech firms and academic institutions, showcasing how smaller companies are leveraging academic resources outside the usual hubs. Discover insights from the latest Alzheimer’s treatment data for Leqembi, which could reshape approaches to the disease. The episode also touches on James Wilson's departure from the University of Pennsylvania, raising questions about the future of gene therapy leadership. These discussions highlight the dynamic nature of the biopharma ecosystem and emerging collaboration trends.

Ask episode

Chapters

Transcript

Episode notes

Intro

00:00 • 3min

Exploring Partnerships in Biotech: The Academia-Industry Interface

02:44 • 5min

Exploring Biotech-Academia Collaborations: Trends and Insights

07:27 • 3min

Exploring Biotech-Academic Collaborations and Alzheimer’s Breakthroughs

10:28 • 2min

Advancements and Challenges in Alzheimer's and Gene Therapy

12:24 • 13min